TY  - GEN
AU  - Lin,Sheng-Li
AU  - Yan,Li-Ying
AU  - Zhang,Xin-Tian
AU  - Yuan,Ju
AU  - Li,Mo
AU  - Qiao,Jie
AU  - Wang,Zhao-Yi
AU  - Sun,Qing-Yuan
TI  - ER-alpha36, a variant of ER-alpha, promotes tamoxifen agonist action in endometrial cancer cells via the MAPK/ERK and PI3K/Akt pathways
SN  - 1932-6203
PY  - 2010///0930
KW  - Alternative Splicing
KW  - Antineoplastic Agents, Hormonal
KW  - pharmacology
KW  - Blotting, Western
KW  - Butadienes
KW  - Cell Line, Tumor
KW  - Cell Membrane
KW  - metabolism
KW  - Cell Proliferation
KW  - drug effects
KW  - Chromones
KW  - Dose-Response Relationship, Drug
KW  - Endometrial Neoplasms
KW  - genetics
KW  - Enzyme Activation
KW  - Estrogen Receptor alpha
KW  - agonists
KW  - Estrogens
KW  - Extracellular Signal-Regulated MAP Kinases
KW  - antagonists & inhibitors
KW  - Female
KW  - Humans
KW  - Morpholines
KW  - Nitriles
KW  - Phosphatidylinositol 3-Kinases
KW  - Phosphoinositide-3 Kinase Inhibitors
KW  - Protein Isoforms
KW  - Proto-Oncogene Proteins c-akt
KW  - Proto-Oncogene Proteins c-myc
KW  - RNA Interference
KW  - Signal Transduction
KW  - Tamoxifen
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1371/journal.pone.0009013
ER  -